Capmatinib and paclitaxel combination: a novel strategy for overcoming challenges in triple-negative breast cancer treatment
- DOI
- 10.1186/s12885-026-16544-8
- Published
- 2026-07-13
- Container
- BMC Cancer
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1186/s12885-026-16544-8,
title = {Capmatinib and paclitaxel combination: a novel strategy for overcoming challenges in triple-negative breast cancer treatment},
author = {Ahmad Habibian Sezavar and Fatemeh Fakhari and Emad Jafarzadeh and Vahideh Montazeri and Amir Shadborestan and Mohammad Abdollahi and Omid Sabzevari and Abbas Kebriaeizadeh and Ruhollah Hosseini and Shima Aliebrahimi and Seyed Nasser Ostad},
year = {2026},
journal = {BMC Cancer},
doi = {10.1186/s12885-026-16544-8},
url = {https://doi.org/10.1186/s12885-026-16544-8}
}RIS
TY - JOUR TI - Capmatinib and paclitaxel combination: a novel strategy for overcoming challenges in triple-negative breast cancer treatment AU - Ahmad Habibian Sezavar AU - Fatemeh Fakhari AU - Emad Jafarzadeh AU - Vahideh Montazeri AU - Amir Shadborestan AU - Mohammad Abdollahi AU - Omid Sabzevari AU - Abbas Kebriaeizadeh AU - Ruhollah Hosseini AU - Shima Aliebrahimi AU - Seyed Nasser Ostad PY - 2026 JO - BMC Cancer DO - 10.1186/s12885-026-16544-8 UR - https://doi.org/10.1186/s12885-026-16544-8 ER -
APA
Sezavar, A. H., Fakhari, F., Jafarzadeh, E., Montazeri, V., Shadborestan, A., Abdollahi, M., Sabzevari, O., Kebriaeizadeh, A., Hosseini, R., Aliebrahimi, S., & Ostad, S. N. (2026). Capmatinib and paclitaxel combination: a novel strategy for overcoming challenges in triple-negative breast cancer treatment. BMC Cancer. https://doi.org/10.1186/s12885-026-16544-8
Source records
- crossref · retrieved 2026-09-27T16:11:21.031Z